Ebola Viral Disease (EVD)
Showing 1 - 25 of >10,000
Host Genetic Factors Underlying Ebola Virus Disease Risk,
Completed
- Ebola Virus Disease
-
Kalkata, Liberia
- +3 more
Aug 18, 2022
Long-Term Neurologic Sequelae of Ebola Virus Disease Survivors
Recruiting
- Ebola Virus Disease
-
Monrovia, LiberiaJohn F. Kennedy Medical Center
Aug 17, 2022
Support to EVD Cured Patients and Their Contacts
Completed
- Ebola Virus Disease
-
Beni, Congo, The Democratic Republic of the
- +3 more
Feb 2, 2022
Ebola Virus Disease Trial in Kenema (rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO))
Not yet recruiting
- Ebola Virus Disease
- rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
-
Kenema, Eastern, Sierra LeoneKenema Government Hospital
Aug 7, 2023
Hemorrhagic Fever, Ebola Trial in Donka (Convalescent Plasma)
Completed
- Hemorrhagic Fever, Ebola
- Convalescent Plasma
-
Donka, GuineaEbola Treatment Center
Jul 2, 2019
Ebola Virus Disease Trial in Kampala (Ebola+D intervention)
Recruiting
- Ebola Virus Disease
- Ebola+D intervention
-
Kampala, UgandaMubende Regional Referal Hospital
Oct 19, 2023
Ebola Virus Disease Trial in Decatur (Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV?G-ZEBOV-GP))
Not yet recruiting
- Ebola Virus Disease
- Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)
-
Decatur, GeorgiaThe Hope Clinic of the Emory Vaccine Center
Oct 20, 2023
Hemorrhagic Fever, Ebola Trial in Congo, The Democratic Republic of the, Sierra Leone (Ansuvimab)
Available
- Hemorrhagic Fever, Ebola
-
Mbandaka, Equateur, Congo, The Democratic Republic of the
- +3 more
May 3, 2022
Ebola Virus Disease Trial in Kinshasa (Ad26.ZEBOV, MVA-BN-Filo vaccine)
Active, not recruiting
- Ebola Virus Disease
- Ad26.ZEBOV, MVA-BN-Filo vaccine
-
Kinshasa, Congo, The Democratic Republic of theL'Institut National de Recherche Biomédicale RDC
Nov 15, 2021
Vaccine-induced Immunity Against Ebola in Previously Vaccinated
Recruiting
- Immune Response
-
Goma, Congo, The Democratic Republic of the
- +1 more
May 18, 2022
Readiness for Ebola Vaccination in Liberia
Not yet recruiting
- Ebola Virus Disease
- Community Clusters
-
Monrovia, Montserrado County, LiberiaMontserrado, Margibi and Lofa Counties
May 24, 2023
Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)
Not yet recruiting
- Sudan Ebola Virus Vaccines
- CAd3
- +3 more
- (no location specified)
Jun 8, 2023
Ebola Virus Disease Trial in Entebbe (Ad26.ZEBOV/MVA-BN-Filo)
Completed
- Ebola Virus Disease
-
Entebbe, UgandaMRC/UVRI & LSHTM Uganda Research Unit
May 10, 2021
Acute Ebola Virus Disease Trial in Atlanta, Omaha (INTERCEPT Plasma)
Terminated
- Acute Ebola Virus Disease
- INTERCEPT Plasma
-
Atlanta, Georgia
- +1 more
Mar 26, 2021
Ebola Virus Disease Trial (REGN3470-3471-3479)
Available
- Ebola Virus Disease
- REGN3470-3471-3479
- (no location specified)
Apr 25, 2022
Ebola Virus Disease Trial in Freetown (Ad26.ZEBOV, MVA-BN-Filo, MenACWY)
Completed
- Ebola Virus Disease
- Ad26.ZEBOV
- +3 more
-
Freetown, Sierra Leone(unnamed)
Jun 22, 2022
Ebola Virus Trial in Monrovia (VSVG-ZEBOV, ChAd3-EBO Z, Placebo)
Completed
- Ebola Virus
- VSVG-ZEBOV
- +2 more
-
Monrovia, LiberiaLiberian Ministry of Health and Social Welfare
Mar 17, 2021
Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)
Completed
- Ebola Virus Disease
- Ad26.ZEBOV vaccine
-
Boende, Province De La Tshuapa, Congo, The Democratic Republic of theHôpital Général de Référence de Boende
Jan 3, 2023
Mobile Point of Care Diagnostic Testing for Ebola Virus Disease
Unknown status
- Ebola Virus Disease
- +5 more
- Differential RPA tests
-
Québec, Canada
- +3 more
Nov 9, 2020
Ebola Virus Disease, Hemorrhagic Fever Trial in Bamako (Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z, Booster-MVA-BN®
Completed
- Ebola Virus Disease
- Hemorrhagic Fever
- Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z
- Booster-MVA-BN® Filo or saline placebo
-
Bamako, MaliCenter for Vaccine Development, Mali
Sep 24, 2019
Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)
Completed
- Ebola Virus Disease
- Marburg Virus Disease
- cAd3-Marburg
- cAd3-EBO-S
-
Oklahoma City, OklahomaOklahoma Blood Institute (OBI)
Aug 2, 2022
After Immunisation With Ebola Virus Vaccines
Completed
- Ebola Virus Disease
- Previously exposed to Ebola vaccine
-
Glasgow, United Kingdom
- +1 more
Jul 14, 2020
Ebola Virus Disease Trial in N'Zerekore (ansuvimab, Ervebo)
Not yet recruiting
- Ebola Virus Disease
- ansuvimab
- Ervebo
-
N'Zerekore, GuineaCentre de Traitement Ebola de N'Zerekore
Oct 14, 2021